Feature Channels: Vaccines

Filters close
Released: 22-Jan-2024 11:05 AM EST
American Society of Anesthesiologists (ASA) Welcomes Vince Loffredo, Ed.D., as Chief Learning Officer
American Society of Anesthesiologists (ASA)

In a strategic move, ASA has hired Vince Loffredo, Ed.D., as its new Chief Learning Officer, where he will oversee the Education, Meetings, and Publications departments, as well as serve as a vital member of ASA’s CEO team.

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Newswise: Remodeling the immune system to fight tuberculosis
Released: 19-Jan-2024 7:05 AM EST
Remodeling the immune system to fight tuberculosis
University of Massachusetts Amherst

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) kills upwards of 1.6 million people a year, making it one of the leading causes of death by an infectious agent worldwide—and that number is only growing larger.

Newswise: We Need a Staph Vaccine: Here’s Why We Don’t Have One
11-Jan-2024 11:00 AM EST
We Need a Staph Vaccine: Here’s Why We Don’t Have One
University of California San Diego

A vaccine for Staphylococcus aureus, one of the most common bacterial infections, would be a game changer for public health. No vaccine candidates have succeeded in clinical trials, but nobody knows why. Researchers at UC San Diego may have figured it out.

Released: 16-Jan-2024 7:05 AM EST
A call for improved CDC communication on adult immunization
CUNY Graduate School of Public Health and Health Policy

In an editorial in the Annals of Internal Medicine, CUNY SPH Distinguished Lecturer Scott Ratzan, Senior Scholar Ken Rabin, and colleagues call for the Centers for Disease Control and Prevention (CDC) to “raise its persuasive communications game” on adult immunization to clinicians and the public.

Newswise: Studies examine different responses to SARS-CoV-2 variants
Released: 12-Jan-2024 12:05 PM EST
Studies examine different responses to SARS-CoV-2 variants
UT Southwestern Medical Center

Two studies led by a researcher at UT Southwestern Medical Center show the effects of different SARS-CoV-2 variants on lung tissue, revealing what may cause some COVID-19 infections to be more severe than others.

Not for public release

This news release is embargoed until 11-Jan-2024 1:00 PM EST Released to reporters: 4-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 11-Jan-2024 1:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Study: Pregnant Women More Likely to Get COVID-19 Vaccine if They Got Other Pregnancy Immunizations
Released: 11-Jan-2024 10:05 AM EST
Study: Pregnant Women More Likely to Get COVID-19 Vaccine if They Got Other Pregnancy Immunizations
Cedars-Sinai

Women who received standard recommended immunizations during their pregnancy were more likely to accept the COVID-19 vaccine, according to new research from Cedars-Sinai. Investigators also identified disparities in vaccination linked to race and insurance status.

Released: 11-Jan-2024 8:50 AM EST
mRNA technology could be possible treatment for rare diseases
University College London

The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.

Released: 10-Jan-2024 10:20 AM EST
Hackensack Meridian Center for Discovery and Innovation Welcomes New Board Member, Dr. Daria Hazuda
Hackensack Meridian Health

Renowned scientist in vaccine and infectious disease research joins prestigious board of visionary leaders

Newswise: image.jpg
Released: 10-Jan-2024 10:05 AM EST
Winter spikes of the flu, COVID-19, and RSV; expert offers tips and advice for staying healthy
Virginia Tech

Federal officials are describing a ‘tripledemic’ of respiratory infections on the rise. Flu, COVID-19, and RSV are spiking, as expected, as we are in the mid-winter months. Lisa M. Lee, a professor of public health at Virginia Tech, answered questions about factors for concern and the importance of vaccination. Lee is an epidemiologist and bioethicist who has worked in public health and ethics for 25 years, including 14 years with CDC.

Released: 9-Jan-2024 2:05 PM EST
Sickle cell raises COVID-19 risk, but vaccination lags
Michigan Medicine - University of Michigan

Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.

Newswise: Protecting newborns: Research lays the groundwork for a lifesaving vaccine
Released: 9-Jan-2024 9:05 AM EST
Protecting newborns: Research lays the groundwork for a lifesaving vaccine
Binghamton University, State University of New York

Researchers from Binghamton University, State University of New York are unraveling the workings of Group B Strep (GBS) infections in pregnant women, which could someday lead to a vaccine.

5-Jan-2024 5:05 PM EST
Vaccine demonstrates potential in delaying relapse of KRAS-mutated pancreatic and colorectal cancers
University of Texas MD Anderson Cancer Center

A vaccine showed potential to prevent relapse of KRAS-mutated pancreatic and colorectal cancers for patients who had previously undergone surgery, according to a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center.

   
5-Jan-2024 4:05 PM EST
Real-world analysis: COVID-19 vaccine strongly effective for children and adolescents during delta and omicron
Perelman School of Medicine at the University of Pennsylvania

In a real-world setting, analysis showed that risk of infection and severe illness was significantly lower for those who were vaccinated against COVID-19, and cardiac conditions did not increase

Not for public release

This news release is embargoed until 8-Jan-2024 5:00 PM EST Released to reporters: 2-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 8-Jan-2024 5:00 PM EST Released to reporters: 2-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Jan-2024 11:05 AM EST
SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung
Ohio State University

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

Newswise:Video Embedded rise-of-the-tripledemic
VIDEO
Released: 5-Jan-2024 1:05 PM EST
Rise of the Tripledemic
Cedars-Sinai

As the new year kicks into full swing, so has a trio of respiratory viruses, creating a so-called tripledemic.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
4-Jan-2024 10:10 AM EST
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
University of California, San Francisco (UCSF)

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.

Newswise: New Study: Is There a Link Between COVID-19 Vaccination and POTS?
Released: 4-Jan-2024 12:05 AM EST
New Study: Is There a Link Between COVID-19 Vaccination and POTS?
Cedars-Sinai

A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic tachycardia syndrome, or POTS.

Released: 3-Jan-2024 7:05 AM EST
RSV vaccines would greatly reduce illness if implemented like flu shots
Yale University

Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease’s significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.

Released: 2-Jan-2024 4:05 PM EST
The ‘tripledemic’ surge
Michigan Medicine - University of Michigan

Study examines the impact of flu, RSV and COVID-19 hitting pediatric emergency departments

Released: 19-Dec-2023 11:05 AM EST
UNM Professor Develops Vaccine to Lower Cholesterol
University of New Mexico Comprehensive Cancer Center

Nearly two in five U.S. adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC).

Newswise: Mineral coatings could enable shelf-stable mRNA therapies
Released: 15-Dec-2023 4:05 PM EST
Mineral coatings could enable shelf-stable mRNA therapies
University of Wisconsin–Madison

A protective mineral coating identified by University of Wisconsin–Madison biomedical engineering researchers could allow powerful messenger RNA therapeutics like COVID-19 vaccines to be stored at room temperature, making them more accessible to lower-resourced communities across the world.In a new paper in the journal Acta Biomaterialia, Professor William Murphy and collaborators in his lab detail how using an optimized mineral coating composition can maintain mRNA activity for up to six months at room temperature.

12-Dec-2023 3:05 PM EST
‘Long flu’ has emerged as a consequence similar to long COVID
Washington University in St. Louis

New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.

Released: 14-Dec-2023 11:05 AM EST
Researchers Pave the Way for Next Generation COVID-19 Immunization Strategies
Beth Israel Deaconess Medical Center

Findings published in the journal Nature by physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) and colleagues suggest that it may be possible to improve protection against COVID-19 by delivering the vaccine directly to the respiratory tract— the primary site of entry in SARS-CoV-2 infection.

   
Released: 13-Dec-2023 1:05 PM EST
‘Tis the season to get vaccinated: How to stay healthy through the holidays
Michigan Medicine - University of Michigan

With virus cases rising and the holidays nigh, three expert from University of Michigan Health give their top 12 tips for avoiding or reducing the impact of COVID-19, flu, RSV, pneumonia and whooping cough in adults and kids.

Newswise: Study: ‘Vaccine Apartheid’ Caused by Gap in Access between Richer and Poorer Countries
Released: 12-Dec-2023 10:05 AM EST
Study: ‘Vaccine Apartheid’ Caused by Gap in Access between Richer and Poorer Countries
University at Albany, State University of New York

The new study is among the first to quantify unmet demand for the vaccine — people who would be willing to be vaccinated if they had access.

     

Not for public release

This news release is embargoed until 11-Dec-2023 5:00 PM EST Released to reporters: 5-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 11-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: T cells tackle new 'Pirola' SARS-CoV-2 variant
7-Dec-2023 5:05 PM EST
T cells tackle new 'Pirola' SARS-CoV-2 variant
La Jolla Institute for Immunology

According to new predictions by La Jolla Institute for Immunology (LJI) researchers, if the new SARS-CoV-2 Pirola variant wants to evade T cells, it isn't doing a very good job.

   
Newswise: Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses
Released: 6-Dec-2023 6:05 PM EST
Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses
University of Cambridge

Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body. They have identified the sequence within the mRNA that causes this to occur and found a way to prevent ‘off-target’ immune responses to enable the safer design of future mRNA therapeutics.

Newswise: UC San Diego Health Infectious Disease Expert on Importance of Annual Influenza Vaccinations
Released: 6-Dec-2023 2:05 PM EST
UC San Diego Health Infectious Disease Expert on Importance of Annual Influenza Vaccinations
UC San Diego Health

Francesca Torriani, MD, infectious disease specialist at UC San Diego Health available to discuss importance of vaccination against influenza.

Newswise:Video Embedded during-holidays-children-s-covid-19-vaccines-protect-entire-family
VIDEO
Released: 4-Dec-2023 10:05 AM EST
During Holidays, Children’s COVID-19 Vaccines Protect Entire Family
Cedars-Sinai

With the holiday season underway, and families and friends gathering to celebrate, a leading Cedars-Sinai Guerin Children’s pediatrician has one word of advice for parents: Vaccinate.

Newswise: Needle-Free Ultrasound Vaccine Delivery #Acoustics23
27-Nov-2023 4:05 PM EST
Needle-Free Ultrasound Vaccine Delivery #Acoustics23
Acoustical Society of America (ASA)

Darcy Dunn-Lawless, a doctoral student at the University of Oxford, is investigating the potential of a painless, needle-free vaccine delivery by ultrasound. The method uses cavitation, which is the formation and popping of bubbles in response to a sound wave. Though initial in vivo tests reported 700 times fewer vaccine molecules were delivered by the cavitation approach compared to conventional injection, the cavitation approach produced a higher immune response. The researchers theorize this could be due to the immune-rich skin the ultrasonic delivery targets. The result is a more efficient vaccine that could help reduce costs and increase efficacy.

Newswise: To Build Better Tuberculosis Vaccines, Saint Louis University Researchers Develop a New Model by Leveraging an Old Vaccine
Released: 29-Nov-2023 12:05 PM EST
To Build Better Tuberculosis Vaccines, Saint Louis University Researchers Develop a New Model by Leveraging an Old Vaccine
Saint Louis University Medical Center

In a paper published in The Journal of Infectious Diseases, Daniel Hoft, M.D., Ph.D., director of the Saint Louis University Center for Vaccine Development, and colleagues report a promising new approach to speed vaccine testing for TB.

Released: 28-Nov-2023 8:05 AM EST
Press Conference Schedule: ASA Invites Media to Register for Acoustics 2023 Sydney
Acoustical Society of America (ASA)

Press conferences for Acoustics 2023 Sydney will be held virtually at 8:00 a.m. AEDT, Dec. 6 and Dec. 7. Topics will focus on a wide range of newsworthy sessions from the upcoming meeting, which runs Dec. 4-8 in Sydney, Australia.

   
Released: 27-Nov-2023 6:05 PM EST
Maternal vaccination against COVID-19 lowered risk of preterm births, Stanford study finds
Stanford University

During the first two years of the pandemic, a COVID-19 infection during pregnancy increased the risk of preterm birth and NICU hospitalizations.

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Seven LJI scientists rank among
Released: 17-Nov-2023 2:05 PM EST
Seven LJI scientists rank among "Highly Cited Researchers"
La Jolla Institute for Immunology

Clarivate calls these scientists "pioneers," noting that ranking on the Highly Cited Researchers list is a sign that a scientist has published significant findings and influenced their field of study.

Released: 16-Nov-2023 3:05 AM EST
Fourth dose of COVID vaccine boosts protection in patients with rheumatic disease
Mass General Brigham

Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Newswise: Survey finds many Americans are letting their guard down during respiratory illness season
Released: 13-Nov-2023 9:05 AM EST
Survey finds many Americans are letting their guard down during respiratory illness season
Ohio State University Wexner Medical Center

Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey by The Ohio State University Wexner Medical Center.



close
1.81275